4 min read

Why pharma L&D needs a focus on soft skills now and for tomorrow

Picture of a corporate man and woman discussing soft skills training
Why pharma L&D needs a focus on soft skills now and for tomorrow
8:16

A pharmaceutical representative can explain a trial endpoint accurately and still miss the question an HCP needs answered. A launch team can know its milestones and still leave an important handoff unresolved. Scientific knowledge is essential. Applying it requires listening, communication, and judgment.

For leaders responsible for pharmaceutical sales training and broader commercial readiness, those behaviors deserve deliberate practice. Woven Health Collective connects science, strategy, and instructional design through its learning capabilities. The practical question is where human-skill development can address a specific performance gap.


Key takeaways: Human skills in pharma commercial training

  • Employer research documents rising importance for human skills across industries, but does not establish growth in pharmaceutical soft-skills training budgets.
  • Pharma engagement research identifies coordination and content-use gaps that provide concrete starting points for commercial learning needs assessments.
  • Prioritize listening, cross-functional communication, and adaptive judgment by connecting each skill to an observable behavior within a defined commercial role.
  • Assess behavior before and after practice, reinforce it through manager coaching, and avoid attributing downstream commercial outcomes to training alone.


What does growing human-skill demand mean for pharma?

Growing demand gives pharmaceutical L&D leaders a reason to examine human-skill development, rather than an off-the-shelf, ready-made prescription for their curriculum.

The World Economic Forum's 2025 employer survey found that the share identifying leadership and social influence as core skills rose 22 percentage points compared with its 2023 edition. Resilience, flexibility, and agility rose 17 points. Empathy and active listening also appeared among its ten core skills.1

While these are cross-industry employer priorities, not pharmaceutical training data, they support a broader corporate learning agenda. The next step is to test that agenda against the behaviors that commercial teams need, using role-specific observations rather than assuming every skill requires equal investment.


Why product knowledge alone cannot address engagement gaps

Product knowledge needs to be paired with the ability to identify an HCP's question and communicate relevant information accurately.

Veeva's Q4 2024 report, released in 2025, reported that 44% of 50 surveyed key opinion leaders perceived a lack of coordination across clinical, medical, and sales teams. It's worth noting that small sample is a useful signal, but not a population-wide estimate.2

Veeva's Q1 2025 report found field teams used content in fewer than half of customer interactions. That observation does not diagnose a soft-skills deficit; content relevance, systems, and workflow may also contribute. But it does make the connection between scientific communication and field execution worth examining.3


Which soft skills should pharma commercial training prioritize?

Start with listening, cross-functional communication, and adaptive judgment where your needs assessment identifies relevant gaps.

Define each skill through a task your learners recognize. A brand leader resolving conflicting launch assumptions needs a different practice exercise from a representative clarifying an HCP's information request.

Active listening in HCP conversations

Active listening should help a representative clarify the HCP's need before selecting an approved response. In a hypothetical scenario, an HCP asks about tolerability. The learner should first establish what information the clinician needs, rather than immediately repeating a prepared message.

Score the learner on asking a relevant follow-up question, accurately summarizing the concern, and responding within their role and approved materials. Connect message clarity to scientific accuracy, not improvisation beyond the evidence.

Cross-functional communication during launch preparation

Cross-functional communication training should make responsibilities, decisions, and handoffs explicit. A launch simulation might ask participants to resolve an unanswered stakeholder request: who owns the next action, what information may be shared, and when should the issue be escalated?

Use engagement planning to give the exercise realistic context. Have compliance and relevant functional leaders define the boundaries. Shared awareness should preserve distinct medical and commercial responsibilities, including the independent purpose of scientific exchange.

Adaptability and judgment in AI-supported work

Adaptive judgment means evaluating a recommendation before acting on it. In an AI-supported call-planning exercise, ask learners to identify missing context, verify information against approved sources, and explain when a suggested action is inappropriate.

Assess their reasoning, not their willingness to accept the output. Build company policies, privacy requirements, and escalation routes into the scenario. Woven's discussion of human oversight provides related perspective on accountability in AI-supported work.



How can you build human skills into commercial learning?

Build human-skill practice into the scientific and commercial tasks your learners already perform. The following offers some potential program designs, that may or may not fit your specific situation.

Choose a disease area or launch scenario, define the target behavior, and let learners attempt it. Provide feedback that identifies what they did and what to change. Repeat with a different HCP context so the exercise tests judgment rather than memorization.

Woven Health Collective's Learning Solutions includes advanced selling skills, coaching, scientific curriculum development, and AI-driven coaching simulations. Those capabilities allow scientific content and communication practice to be considered together.

For team exercises, distinguish engagement from proficiency. An immersive learning experience can create opportunities to observe collaboration. Attendance or enthusiasm alone does not establish skill development.


How should you measure behavior change beyond completion?

Measure the specific behavior you intended to change, using comparable assessments before training and after learners have had opportunities to apply it.

A listening rubric might assess whether the learner asks a relevant question, confirms their understanding, selects appropriate approved information, and identifies the correct next step. Have evaluators calibrate their scoring against the same examples.

Schedule follow-up observations and ask managers to coach one behavior at a time. Choose intervals that fit the work. Use simulations or appropriately authorized observations; avoid collecting sensitive conversation data without ensuring proper processes.

Commercial outcomes require separate analysis. Changes in access or launch performance have multiple possible causes. Pair behavioral evidence with operational indicators, and distinguish association from causation. The same principle underlies measurement beyond activity.


What should pharmaceutical commercial leaders prioritize next?

Begin with one consequential performance gap and a defined learner group. Review whether the obstacle is knowledge, behavior, process, incentives, or technology before commissioning more training.

If behavior is part of the problem, specify what improvement looks like, design a relevant practice exercise, and equip managers to reinforce it. Protect scientific rigor throughout. Communication training should help learners use evidence appropriately, never dilute it.

The broader demand for human skills makes this a timely curriculum question. Pharma's engagement challenges make it concrete. Your opportunity is to connect a documented need to an observable behavior, then evaluate the change honestly.


References

  1. World Economic Forum, The Future of Jobs Report 2025, Skills Outlook. Published January 7, 2025. Cross-industry employer survey; the comparisons describe skills priorities, not pharma training expenditure.
  2. Veeva Pulse Field Trends Report, Q4 2024. Released February 2025. The coordination finding comes from a survey of 50 KOLs conducted in 2024, separate from the report's aggregated CRM activity analysis.
  3. Veeva Pulse Field Trends Report, Q1 2025. Released May 2025. Industry-specific vendor research on field engagement and content use; it does not test soft-skills training effectiveness.


FAQs about soft skills in pharmaceutical commercialization